EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Whole-brain mapping reveals the divergent impact of ketamine on the dopamine system

Malika S Datta, Yannan Chen, Shradha Chauhan, Jing Zhang, Estanislao Daniel De La Cruz, Cheng Gong, Raju Tomer

Cell Reports · 2023

DOI: 10.1016/j.celrep.2023.113491 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2023. Verfasst von Malika S Datta und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Columbia University, New York, NY 10027, USA; Mortimer B. Zuckerman Mind Brain and Behavior Institute, Columbia Un…. Hauptthemen laut MEDLINE: Ketamine. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIMH NIH HHS, National Institutes of Health, Columbia University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ketamine is a multifunctional drug with clinical applications as an anesthetic, pain management medication, and a fast-acting antidepressant. However, it is also recreationally abused for its dissociative effects. Recent studies in rodents are revealing the neuronal mechanisms mediating its actions, but the impact of prolonged exposure to ketamine on brain-wide networks remains less understood. Here, we develop a sub-cellular resolution whole-brain phenotyping approach and utilize it in male mice to show that repeated ketamine administration leads to a dose-dependent decrease in dopamine neurons in midbrain regions linked to behavioral states, alongside an increase in the hypothalamus. Additionally, diverse changes are observed in long-range innervations of the prefrontal cortex, striatum, and sensory areas. Furthermore, the data support a role for post-transcriptional regulation in enabling ketamine-induced neural plasticity. Through an unbiased, high-resolution whole-brain analysis, this study provides important insights into how chronic ketamine exposure reshapes brain-wide networks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineMaleMiceAnimalsDopamineBrainBrain MappingAntidepressive Agents

Stichwörter der Autor:innen

CP: Neuroscienceantidepressantdopamineketaminemodulationneural circuit adaptationsplasticitywhole-brain mapping

Substanzen

KetamineDopamineAntidepressive Agents

Autor:innen und Institutionen

  • Department of Biological Sciences, Columbia University, New York, NY 10027, USA; Mortimer B. Zuckerman Mind Brain and Behavior Institute, Columbia University, New York, NY 10027, USA.
  • Department of Biological Sciences, Columbia University, New York, NY 10027, USA; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.
  • Department of Biological Sciences, Columbia University, New York, NY 10027, USA.
  • Department of Biological Sciences, Columbia University, New York, NY 10027, USA; Mortimer B. Zuckerman Mind Brain and Behavior Institute, Columbia University, New York, NY 10027, USA; Department of Biomedical Engineerin…

Förderung

  • NIMH NIH HHS
  • National Institutes of Health
  • Columbia University
  • OpenAI

Zitieren

APA

Datta, M. S., Chen, Y., Chauhan, S., Zhang, J., De La Cruz, E. D., Gong, C., & Tomer, R. (2023). Whole-brain mapping reveals the divergent impact of ketamine on the dopamine system. Cell Reports. https://doi.org/10.1016/j.celrep.2023.113491

Vancouver

Datta MS, Chen Y, Chauhan S, Zhang J, De La Cruz ED, Gong C, et al. Whole-brain mapping reveals the divergent impact of ketamine on the dopamine system. Cell Reports. 2023. doi:10.1016/j.celrep.2023.113491

BibTeX
@article{Datta2023,
  author = {Datta, Malika S and Chen, Yannan and Chauhan, Shradha and Zhang, Jing and De La Cruz, Estanislao Daniel and Gong, Cheng and Tomer, Raju},
  title = {Whole-brain mapping reveals the divergent impact of ketamine on the dopamine system},
  journal = {Cell Reports},
  year = {2023},
  doi = {10.1016/j.celrep.2023.113491}
}
Kostenlos starten →